The HBM-VNR model could also be used to predict the effects on neuronal firing and circuit behaviour following the introduction of a pharmacological agent or channelopathy as was showcased in Sections "KCNA1 mutation" and "CACNA1 A rocker and tottering mutations". The gene discussed is KCNA1; the disease is channelopathy.